TMCI Treace Medical Concepts Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TMCI

Price (delayed)

$11

Market cap

$679.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.81

Enterprise value

$735.22M

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The ...

Highlights
The equity has surged by 128% year-on-year
TMCI's revenue is up by 32% YoY and by 7% QoQ
Treace Medical Concepts's quick ratio has decreased by 19% QoQ
The company's net income fell by 16% YoY and by 3.9% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.treace.com
Peers: NVRO OFIX NURO

Key stats

What are the main financial stats of TMCI
Market
Shares outstanding
61.76M
Market cap
$679.31M
Enterprise value
$735.22M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.92
Price to sales (P/S)
3.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.93
Earnings
Revenue
$187.12M
EBIT
-$44.36M
EBITDA
-$36.55M
Free cash flow
-$46.03M
Per share
EPS
-$0.81
Free cash flow per share
-$0.76
Book value per share
$2.24
Revenue per share
$3.07
TBVPS
$3.78
Balance sheet
Total assets
$251.91M
Total liabilities
$113.97M
Debt
$68.9M
Equity
$137.94M
Working capital
$153.33M
Liquidity
Debt to equity
0.5
Current ratio
4.4
Quick ratio
3.58
Net debt/EBITDA
-1.53
Margins
EBITDA margin
-19.5%
Gross margin
81.2%
Net margin
-26.5%
Operating margin
-27.5%
Efficiency
Return on assets
-20%
Return on equity
-34%
Return on invested capital
-17.6%
Return on capital employed
-21.4%
Return on sales
-23.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TMCI stock price

How has the Treace Medical Concepts stock price performed over time
Intraday
2.71%
1 week
5.77%
1 month
-10.28%
1 year
-57.36%
YTD
-13.73%
QTD
-15.71%

Financial performance

How have Treace Medical Concepts's revenue and profit performed over time
Revenue
$187.12M
Gross profit
$151.94M
Operating income
-$51.43M
Net income
-$49.53M
Gross margin
81.2%
Net margin
-26.5%
The operating income has contracted by 48% YoY and by 7% from the previous quarter
TMCI's revenue is up by 32% YoY and by 7% QoQ
Treace Medical Concepts's gross profit has increased by 31% YoY and by 7% from the previous quarter
The company's net income fell by 16% YoY and by 3.9% QoQ

Growth

What is Treace Medical Concepts's growth rate over time

Valuation

What is Treace Medical Concepts stock price valuation
P/E
N/A
P/B
4.92
P/S
3.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.93
The EPS has declined by 5% year-on-year and by 3.8% since the previous quarter
The equity has surged by 128% year-on-year
TMCI's P/B is 38% below its last 4 quarters average of 7.9
The P/S is 48% below the last 4 quarters average of 6.9
TMCI's revenue is up by 32% YoY and by 7% QoQ

Efficiency

How efficient is Treace Medical Concepts business performance
Treace Medical Concepts's return on invested capital has increased by 45% YoY and by 2.2% QoQ
The return on equity has increased by 44% year-on-year and by 10% since the previous quarter
Treace Medical Concepts's ROA has increased by 28% YoY and by 6% from the previous quarter
The return on sales is up by 13% year-on-year and by 2.5% since the previous quarter

Dividends

What is TMCI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TMCI.

Financial health

How did Treace Medical Concepts financials performed over time
TMCI's total assets is 121% greater than its total liabilities
TMCI's total assets has surged by 58% year-on-year and by 4.8% since the previous quarter
Treace Medical Concepts's current ratio has decreased by 22% from the previous quarter
TMCI's debt is 50% lower than its equity
The equity has surged by 128% year-on-year
The debt to equity has plunged by 56% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.